Ocular Therapeutix, Inc OCUL
8 insiders sold $1.2M on the market, none bought
Form 4Open-market buys and sales are the trades an insider chose to make. Grants, option exercises and shares withheld for tax are pay; they show under All.
A year of insider trades, day by day
Open-market buys and sales by officers and directors · Form 4, since Nov 24, 2025
$0 bought on 0 days, $1.2M sold on 7 days. Each square is a day; click one for its Form 4.
Buys and sales by insider
Who traded · Form 4, added up
| Insider | Bought | Sold | Latest |
|---|---|---|---|
| Pravin Dugel See Remarks, Director |
- | $407K | Aug 24, 2026 |
| Namrata Saroj Chief Business Officer |
- | $232K | Nov 5, 2026 |
| Jeffrey S. Heier Chief Scientific Officer |
- | $137K | Oct 2, 2026 |
| Peter Kaiser Chief Development Officer |
- | $127K | Oct 2, 2026 |
| Nadia Waheed Chief Medical Officer |
- | $123K | Jun 3, 2026 |
| Todd Anderman Chief Legal Officer |
- | $87K | Oct 8, 2026 |
| Sanjay Nayak Chief Strategy Officer |
- | $36K | Aug 24, 2026 |
| Donald Notman Chief Operating Officer |
- | $11K | Aug 31, 2026 |
Owned after: shares held right after the person's latest buy or sale, from the Form 4 the date links to. % of shares: that holding over the shares outstanding on the latest cover page. Only people who bought or sold in this period are listed, and options, restricted units and shares held by others are not counted, so the rows are not a total of what insiders own.
Trade by trade, newest first
Every trade · each date links to its Form 4
Of 14 open-market sales by officers and directors, 1 came in the 30 days before a 10-Q, a 10-K or a results 8-K. Dates only, from the filing index; most companies close the window for insider trades in the weeks before results, so a trade there is often under a 10b5-1 plan.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Nov 5, 2026 | Namrata Saroj | Sale (10b5-1) | -35,370 | 232K |
| Oct 8, 2026 | Todd Anderman | Sale (10b5-1) | -11,984 | 87K |
| Oct 2, 2026 | Jeffrey S. Heier | Sale (10b5-1) | -10,869 | 77K |
| Oct 2, 2026 | Peter Kaiser | Sale (10b5-1) | -9,990 | 70K |
| Aug 31, 2026 | Donald Notman | Sale | -1,099 | 11K |
| Aug 24, 2026 | Pravin Dugel | Sale (10b5-1) | -21,649 | 233K |
| Aug 24, 2026 | Jeffrey S. Heier | Sale (10b5-1) | -3,296 | 36K |
| Aug 24, 2026 | Sanjay Nayak | Sale (10b5-1) | -1,897 | 20K |
| Aug 24, 2026 | Peter Kaiser | Sale (10b5-1) | -3,035 | 33K |
| Jun 3, 2026 | Nadia Waheed | Sale (10b5-1) | -14,828 | 123K |
| May 26, 2026 | Sanjay Nayak | Sale (10b5-1) | -1,858 | 15K |
| May 26, 2026 | Jeffrey S. Heier | Sale (10b5-1) | -3,018 | 25K |
| May 26, 2026 | Peter Kaiser | Sale (10b5-1) | -2,967 | 24K |
| May 26, 2026 | Pravin Dugel | Sale (10b5-1) | -21,156 | 173K |
Sources
Form 4s from SEC's filing index. An insider files one within two business days of a trade.
Also
Insider selling plans: the 10b5-1 plans and Form 144 notices behind planned sales.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/OCUL/export.csv") into a cell.